Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novavax raises $20mm in PIPE financing

Executive Summary

Novavax Inc. (develops drug delivery platforms for women's health and infectious disease therapeutics) has grossed approximately $20mm through a private placement, selling about 4.6mm common shares to new backer Kleiner Perkins Caufield & Byers, which bought $12.5mm (62.5%), and existing investor Prospect Venture Partners, which purchased $7.5mm. The shares were priced at $4.35 each, a 5% discount to the market average.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies